Get my own profile
Public access
View all2 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Pere PuigserverProfessor of Cell and Cancer Biology, Harvard Medical SchoolVerified email at dfci.harvard.edu
- Bruce M. SpiegelmanStanley J. Korsmeyer Professor, Harvard Medical School and Dana-Farber Cancer InstituteVerified email at dfci.harvard.edu
- Jan Nedergaardprofessor of physiology, Stockholm UniversityVerified email at su.se
- Anna SundgrenCVRM Late Stage Development AstraZenecaVerified email at astrazeneca.com
- Jorrit HornbergAstraZenecaVerified email at astrazeneca.com
- Irina ShabalinaDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm UniversityVerified email at wgi.su.se
- Nina KrutrökRIA iMed AstraZenecaVerified email at AstraZeneca.com
- Johan JirholtRIA iMed, AstraZenecaVerified email at astrazeneca.com
- Rikard PehrsonRIA iMed, AstraZenecaVerified email at astrazeneca.com
- Jukka HakkolaUniversity of OuluVerified email at oulu.fi
- Clary ClishSenior Director, Metabolomics, Broad Institute of MIT and HarvardVerified email at broadinstitute.org
Follow
Ulf Andersson
Head of Preclincal Safety and Translational Pharmacology
Verified email at debiopharm.com